Cargando…
Update on the Management of Uveitic Macular Edema
Uveitic macular edema (ME) is a frequent complication in 8.3% of uveitis patients and is a leading cause of serious visual impairment in about 40% of cases. Despite the numerous available drugs for its treatment, at least a third of patients fail to achieve satisfactory improvement in visual acuity....
Autor principal: | Teper, Slawomir Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470573/ https://www.ncbi.nlm.nih.gov/pubmed/34575244 http://dx.doi.org/10.3390/jcm10184133 |
Ejemplares similares
-
Update in treatment of uveitic macular edema
por: Koronis, Spyridon, et al.
Publicado: (2019) -
Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018) -
Topical interferon therapy in uveitic macular edema
por: Kawali, Ankush, et al.
Publicado: (2022) -
Intravitreal Diclofenac for Refractory Uveitic Cystoid Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2013) -
Intensive topical interferon therapy in uveitic macular edema
por: Kawali, Ankush, et al.
Publicado: (2022)